Volume 180, Issue 3 pp. 678-679
Research Letter

Use of absolute risk measurements in observational dermatology studies: important information for decision-making is frequently absent

L.A. Tjahjono

Corresponding Author

L.A. Tjahjono

Mayo Clinic School of Medicine, Rochester, MN, U.S.A

Search for more papers by this author
A. Cline

A. Cline

Center for Dermatology Research, Department of Dermatology, Winston-Salem, NC, U.S.A

Search for more papers by this author
W.W. Huang

W.W. Huang

Center for Dermatology Research, Department of Dermatology, Winston-Salem, NC, U.S.A

Search for more papers by this author
S.R. Feldman

S.R. Feldman

Center for Dermatology Research, Department of Dermatology, Winston-Salem, NC, U.S.A

Department of Pathology, Winston-Salem, NC, U.S.A

Division of Public Health Sciences - Wake Forest School of Medicine, Winston-Salem, NC, U.S.A

Search for more papers by this author
First published: 16 October 2018
Funding sources: none.
Conflicts of interest: S.R.F. has received research, speaking and/or consulting support from Galderma, GSK/Stiefel, Almirall, LEO Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Ortho Dermatology, AbbVie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. S.R.F. is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment.
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.